95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.14%
Revenue growth 1.25-1.5x RGLD's 10.35%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
28.42%
Gross profit growth above 1.5x RGLD's 1.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
30.60%
Positive EBIT growth while RGLD is negative. John Neff might see a substantial edge in operational management.
30.60%
Positive operating income growth while RGLD is negative. John Neff might view this as a competitive edge in operations.
22.41%
Positive net income growth while RGLD is negative. John Neff might see a big relative performance advantage.
23.53%
Positive EPS growth while RGLD is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.53%
Positive diluted EPS growth while RGLD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while RGLD stands at 5.58%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
34.67%
OCF growth 1.25-1.5x RGLD's 27.40%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
35.67%
FCF growth under 50% of RGLD's 529.89%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
126.65%
10Y revenue/share CAGR at 75-90% of RGLD's 167.30%. Bill Ackman would press for new markets or product lines to narrow the gap.
61.68%
5Y revenue/share CAGR at 50-75% of RGLD's 82.76%. Martin Whitman would worry about a lagging mid-term growth trajectory.
26.90%
3Y revenue/share CAGR similar to RGLD's 26.88%. Walter Schloss would assume both companies experience comparable short-term cycles.
135.70%
10Y OCF/share CAGR under 50% of RGLD's 12775.41%. Michael Burry would worry about a persistent underperformance in cash creation.
65.00%
5Y OCF/share CAGR 1.25-1.5x RGLD's 50.14%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
45.99%
3Y OCF/share CAGR above 1.5x RGLD's 30.40%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
62.55%
Below 50% of RGLD's 560.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
59.02%
5Y net income/share CAGR 1.25-1.5x RGLD's 53.00%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
52.81%
3Y net income/share CAGR 75-90% of RGLD's 62.09%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
125.25%
10Y equity/share CAGR above 1.5x RGLD's 37.27%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-2.02%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
3.78%
Positive short-term equity growth while RGLD is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.93%
Firm’s AR is declining while RGLD shows 14.60%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.20%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.65%
We have a declining book value while RGLD shows 1.01%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-18.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-5.92%
We cut SG&A while RGLD invests at 43.30%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.